DOJ Subpoenas Gilead Over HIV Drugs

Law360, New York (June 13, 2011, 6:14 PM EDT) -- Gilead Sciences Inc. said Friday that prosecutors in California had subpoenaed the pharmaceutical company, requesting information about the manufacturing, quality control and distribution practices of various drugs used to treat HIV.

The company said the U.S. Attorney's Office for the Northern District of California asked for documents regarding HIV medications Atripla, Emtriva, Truvada and Viread, as well as for hepatitis B and herpes treatment Hepsera and pulmonary arterial hypertension treatment Letairis. Prosecutors also asked for information about Gilead's investigation into fixed-dose combinations of Truvada and recently...
To view the full article, register now.